Duff, Christopher J <br/><br/>
PCSK9: an emerging target for treatment of hypercholesterolemia.  [electronic resource] 

 -  Expert opinion on therapeutic targets  Feb 2011 
 - 157-68 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7631 
<br/><br/><label>Standard No.: </label>10.1517/14728222.2011.547480  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Neutralizing--immunology<br/>Cholesterol, LDL--blood<br/>Humans<br/>Hypercholesterolemia--drug therapy<br/>Molecular Targeted Therapy<br/>Proprotein Convertase 9<br/>Proprotein Convertases<br/>Protein Binding<br/>RNA Interference<br/>Receptors, LDL--genetics<br/>Serine Endopeptidases--genetics<br/>Serine Proteinase Inhibitors--pharmacology